论文部分内容阅读
去年,湖南省常德市一场以三株口服液引发的索赔300万元的官司,给财大气粗的三株集团带来几乎是毁灭性的灾难;年产值达百亿元的生物制药厂被迫停产,号称全国最大的营销网络也大举萎缩,12万名员工下岗。据三株集团估算,这场官司给三株带来的直接损失达40亿元,净资产损失10多亿元,几年蓄积的无形资产也元气大伤。一年多来,关于三株的各种传闻不绝于耳,三株集团大病一场如今是否依然卧床不起?
Last year, a 3 million-yuan lawsuit in Changde City, Hunan Province, caused an almost catastrophic disaster for the rich and powerful three groups; the bio-pharmaceutical plant with an annual output value of 10 billion yuan was forced to stop production. The country’s largest marketing network is also shrinking and 120,000 employees are laid off. According to the estimates of the three groups, the direct losses caused by the lawsuit to the three strains amounted to 4 billion yuan, and the loss of net assets was more than 1 billion yuan. The intangible assets accumulated in the past few years were also seriously injured. Over the past year or so, all kinds of rumors about the three strains have been heard. Did the three strains fall ill now that they are still bedridden?